review on glp-1 agonists and psychiatric effects Prospects of Therapies for Addiction Mental Health Comorbidities-Quo Vadis?: A New Publication Alert 🚨🔬 Kyle

(PubMed) Andres M, Sivera F, Falzon L, Buchbinder R, Carmona L

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have garnered recognition as potentially revolutionary therapeutic modalities for MASLD/MASH management, offering multifaceted benefits extending beyond glycemic regulation

Heikkila, P., Parpala, T., Lukkarinen, O., Weber, M

benefit analysis in long-term therapy DPP-4 inhibitors are a safe and well-tolerated drug class, ideal for older adults, type 2 diabetes patients, and those with kidney manifestations

Author contributions ZL: Data curation, Validation, Conceptualization, Project administration, Methodology, Visualization, Formal analysis, Supervision, Writing original draft, Writing review & editing, Investigation

Any other public-facing educators that have formal science training and do regular posting of content came in several years after you initiated it